Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011849 (diabetes)
 277,896 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The effects of streptozotocin(SZ)-induced diabetes on renal ornithine decarboxylase (ODC) activity, the rate-limiting enzyme in polyamine biosynthesis, were studied. Sixteen hours after the injection of SZ, renal ODC activity increased 50% above that of the vehicle-injected controls. The maximum increase in activity--600%--was observed from 24 to 72 h after SZ. Within a week, ODC activity fell below control levels and remained suppressed during a 3 wk follow-up period. Insulin treatment within 10 h of the SZ injection prevented the increase of ODC activity; however, insulin given after enzyme activity had increased did not restore ODC activity to control levels. The early increase of ODC activity occurred in the presence of mild hyperglycemia without ketosis or hyperglucagonemia, but the levels were much higher in severely diabetic animals. Adrenalectomy, performed before the initial increase in enzyme activity, prevented the subsequent increase in diabetic animals; however, when adrenalectomy was performed after the enzyme had increased, enzyme activity did not normalize.
Diabetes 1980 Jul
PMID:Effect of streptozotocin-induced diabetes on renal ornithine decarboxylase activity. 644 42

We have previously shown that a factor(s) in rat serum induces ornithine decarboxylase (ODC) in incubated muscle and that its activity is diminished in sera from diabetic rats. To characterize this factor further, we have studied some of its physicochemical and biologic properties. As judged from its ability to induce ODC in the incubated rat soleus muscle, the factor is protease-sensitive and both heat- and acid-stable. In untreated whole serum its activity is associated with a high-molecular-weight fraction whereas after boiling at pH 5.5, activity is principally in a fraction with a molecular weight between 3500 and 12,000 daltons. The activity of the factor is diminished in hypophysectomized, starved, and aged as well as diabetic rats. In diabetic rat serum it is restored to normal by the addition of a purified somatomedin, multiplication-stimulating activity. These findings suggest that the "ODC inducing factor" is a low-molecular-weight peptide and that it has many of the characteristics of a somatomedin.
Diabetes 1982 Jun
PMID:Partial characterization of an insulin-dependent serum factor that regulates ornithine decarboxylase in skeletal muscle. 675 67

The influence of streptozotocin-induced diabetes on discrete stages of matrix-induced endochondral bone formation has been investigated. Mesenchymal cell proliferation was inhibited in diabetic rats as evidenced by a 65% reduction of ornithine decarboxylase (ODC) activity and a 56% reduction of [3H]thymidine incorporation per microgram DNA compared to nondiabetic controls; the inhibition was prevented by insulin treatment. In diabetic animals, chondrogenesis on day 7 was reduced by 49% compared to control animals as assessed by 35SO4 incorporation. Exogenous insulin was stimulatory to cartilage development when present during days 0 through 4 (mesenchymal cell proliferation). Calcification of cartilage and osteogenesis were reduced by more than 50% in diabetic rats and corrected by insulin as measured by alkaline phosphatase activity and 45Ca incorporation. Decreased in vivo endochondral bone growth and development during diabetes is the result of 1) inhibition of insulin-dependent mesenchymal cell proliferation, 2) decreased and delayed cartilage formation due to impaired mesenchymal cell proliferation, 3) decreased and delayed vascular invasion prior to chondrolysis and osteogenesis, and 4) reduced insulin-dependent calcification and ossification.
 ...
PMID:Influence of experimental diabetes and insulin on matrix-induced cartilage and bone differentiation. 698 62

The activity of ornithine decarboxylase, the rate-controlling enzyme in polyamine biosynthesis, was determined in tissues of normal control rats and rats made diabetic with streptozotocin. In untreated diabetic rats fed ad libitum, ornithine decarboxylase activity was markedly diminished in liver, skeletal muscle, heart and thymus. Ornithine decarboxylase was not diminished in a comparable group of diabetic rats maintained on insulin. Starvation for 48h decreased ornithine decarboxylase activity to very low values in tissues of both normal and diabetic rats. In the normal group, refeeding caused a biphasic increase in liver ornithine decarboxylase; there was a 20-fold increase in activity at 3h followed by a decrease in activity, and a second peak between 9 and 24h. Increases in ornithine decarboxylase in skeletal muscle, heart and thymus were not evident until after 24-48h of refeeding, and only a single increase occurred. The increase in liver ornithine decarboxylase in diabetic rats was greater than in normal rats after 3h of refeeding, but there was no second peak. In peripheral tissues, the increase in ornithine decarboxylase with refeeding was diminished. Skeletal-muscle ornithine decarboxylase is induced more rapidly when meal-fed rats are refed after a period without food. Refeeding these rats after a 48h period without food caused a 5-fold increase in ornithine decarboxylase in skeletal muscle at 3h in control rats but failed to increase activity in diabetic rats. When insulin was administered alone or together with food to the diabetic rats, muscle ornithine decarboxylase increased to activities even higher than in the refed controls. In conclusion, these findings indicate that the regulation of ornithine decarboxylase in many tissues is grossly impaired in diabetes and starvation. They also suggest that polyamine formation in vivo is an integral component of the growth-promoting effect of insulin or some factor dependent on insulin.
 ...
PMID:Ornithine decarboxylase activity in insulin-deficient states. 701 16

Previous studies in vivo have shown that the activity of ornithine decarboxylase (ODC), the rate-controlling enzyme in polyamine biosynthesis, is markedly decreased in muscle of diabetic rats and is restored to normal by insulin therapy. Also, muscle ODC is diminished by starvation and increased by refeeding. To investigate the basis for these findings, the regulation of ODC was studied in vitro using rat soleus and extensor digitorum longus muscles. Incubation of muscles from fed rats in Krebs-Henseleit solution resulted in a 75% decrease in ODC activity within 1 h. Addition of insulin and amino acids had no effect; however, 50% rat serum increased ODC activity four- to seven-fold after the initial decrease. Rat serum also increased ODC in muscles from starved rats. The effect of serum was blocked by both cycloheximide and antinomycin D. Serum from diabetic rats was only 50% as effective as serum from normal rats in increasing ODC activity. Addition of physiologic levels of insulin to diabetic serum had no effect; however, treatment of diabetic rats with insulin in vivo restored serum activity to normal. These findings suggest that insulin modulates the synthesis of ODC via production of a second circulating factor, the activity of which is diminished in serum of diabetic rats. They also suggest that the stimulation of polyamine biosynthesis by this factor may be an integral component of the growth-promoting effect of insulin on muscle in vivo.
Diabetes 1981 Aug
PMID:Regulation of ornithine decarboxylase in skeletal muscle: evidence for the involvement of an insulin-dependent serum factor. 701 71

Ornithine decarboxylase (L-ornithine carboxylase; EC 4.1.1.17) (ODC) activity falls to approximately 30% of the control value in diabetic rat kidney 4 weeks after induction of diabetes with alloxan. The extent of this fall was related to the severity of diabetes based on parameters such as body weight, blood glucose and adipose tissue weight. The diabetic rat kidney did not attain the same high level of activity of ODC as did that of the control group 24 h after unilateral nephrectomy, however, the percentage stimulation in the two groups was essentially similar.
 ...
PMID:Changes in ornithine decarboxylase in kidney in experimental diabetes. Correlation with severity of diabetes and effects of unilateral nephrectomy. 744 51

The role of ornithine decarboxylase (ODC) and polyamines in kidney hypertrophy is controversial. Since part of this controversy could be related to differences in the model system used by the different authors, we studied the changes in renal ODC and polyamines in six different models of kidney hypertrophy in mice, including compensatory renal hypertrophy produced by unilateral nephrectomy, experimental diabetes, potassium depletion and treatment with hormones such as testosterone, thyroxine and fluorocortisone. Only in the case of renal hypertrophy produced by testosterone administration was there a significant increase in ODC activity and putrescine content in the kidneys. However, the concomitant treatment with difluoromethylornithine (DFMO), an irreversible inhibitor of ODC, as a 2% solution in the drinking water completely abolished the increase of renal ODC, but the kidney weights increased and other androgenic effects, such as the induction of renal beta-glucuronidase, were not affected. Moreover, DFMO-treatment did not prevent the kidney enlargement produced in other types of hypertrophy, even in the cases associated with hyperplasia. The present results support the premise that, at least in mice, the increase in ODC activity and polyamine biosynthesis is not required for kidney growth, and also that in most cases renal enlargement is not accompanied by any increase in the polyamine content.
 ...
PMID:An evaluation of the role of polyamines in different models of kidney hypertrophy in mice. 747 58

Regeneration of the remnant pancreas after more than 92% pancreatectomy with or without insulin treatment was studied in dogs. All dogs developed diabetes mellitus (DM) immediately after surgery. For the dogs in insulin-treated group, porcine insulin (NPH) was injected subcutaneously daily to maintain the fasting blood sugar levels from 70 to 130 mg/dl. All dogs without insulin treatment died within 7 weeks after surgery, whereas 87.5% of the dogs receiving insulin treatment survived until 12 weeks, and 57.1% of surviving dogs were free of DM. DNA and RNA synthesis and ornithine decarboxylase (ODC) activity in the remnant pancreatic tissue 3 days after surgery were significantly greater in the insulin-treated dogs than in the untreated dogs. Endogenous insulin secretion, exocrine pancreatic function and the regeneration rate of the remnant pancreas at the 6-7th week were significantly better in the insulin-treated dogs. Furthermore, the regeneration rate at the 6-7th week was highly correlated with DNA and RNA synthesis and ODC activity in the remnant pancreas tissue 3 days after surgery. After major pancreatectomy in dogs, insulin treatment enhances the proliferation of the remnant pancreas during the early period and maintains endogenous insulin secretion for a long period, prolonging survival and promoting pancreatic regeneration.
 ...
PMID:[Pancreatic regeneration after major pancreatectomy and effect of insulin administration in dogs]. 768 21

Formation of polyamines has previously been shown to play an important role for initial kidney growth in experimental diabetes, as treatment of diabetic rats with a selective ornithine decarboxylase (ODC) inhibitor, initiated immediately after diabetes induction, abolishes the initial kidney growth. In order to investigate the role of polyamine formation for the maintenance of diabetic kidney hypertrophy, ODC inhibition was initiated after manifest kidney hypertrophy had occurred. The kidney weight in diabetic rats was significantly larger than in control rats after a diabetes duration of 7, 14, 50 and 71 days and the total glomerular volume was increased in kidneys from diabetic rats after a diabetes duration of 71 days. Renal activity of ODC was increased in diabetic rats throughout the study period of 71 days. Treatment of diabetic rats with the selective ODC inhibitor di-fluoro-methyl-ornithine (DFMO) was maintained for two periods (days 7-14 and days 50-71). DFMO treatment had no effect on 24-h food consumption, blood glucose concentration or body weight. However, despite almost total inhibition of the kidney ODC activity, there was no effect on kidney growth or total glomerular volume in the DFMO treated diabetic rats compared to placebo treated diabetic rats. Finally, the urinary albumin excretion was markedly increased in diabetic rats with no effects of ODC-inhibition. In conclusion, inhibition of ODC initiated in diabetic rats with manifest kidney enlargement had no effect on renal size, glomerular volume or urinary albumin excretion. These findings together with our previous findings indicate that the role of polyamines in diabetic kidney enlargement is restricted to the first week after diabetes induction.
 ...
PMID:Inhibition of renal ornithine decarboxylase activity fails to reduce kidney size and urinary albumin excretion in diabetic rats with manifest kidney hypertrophy. 779 31

Previous studies have demonstrated high concentrations of polyamines in neoplastic tissue and embryos and these compounds are therefore believed to play a role in cellular growth and embryonic development. Maternal diabetes causes embryonic dysmorphogenesis and alterations in embryonic polyamine concentrations may contribute to this process. In the present study we have measured the contents of DNA, putrescine, spermidine and spermine in embryos on days 10 and 11 of gestation in normal and diabetic rats. We also estimated the activity of ornithine decarboxylase (ODC) in embryos on days 9-11. We found that maternal diabetes causes delayed growth as reflected by decreased content of DNA on day 11 in the embryos of the diabetic group. Both the polyamine content and ODC activity were altered in the embryos of diabetic rats. Thus, the polyamines were increased on day 10 and decreased on day 11, and the ODC activity was decreased in a down-regulated manner in day-10 embryos of the diabetic rats. These findings suggest that polyamine metabolism is involved in the dysmorphogenesis of diabetic pregnancy.
 ...
PMID:Ornithine decarboxylase activity and concentrations of polyamines in embryos of diabetic rats. 786 37


<< Previous 1 2 3 4 Next >>